Company intelligence / Profile preview

Clear Choice Therapeutics

Athens, Georgia, United Statesclearchoicetherapeutics.com ↗

Ownership: Private
Development stage: Other

Overview

Clear Choice Therapeutics has developed the PREVENT™ Kit, a powered suction pump device for wound care. The product received FDA 510(k) clearance in February 2024 and was found to be substantially equivalent to predicate devices with no new safety or effectiveness concerns identified during preclinical studies[3].

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Clear Choice Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clear Choice Therapeutics.

Explore the full profile